MicroRNAs align with accessible sites in target mRNAs

Journal of Cellular Biochemistry

Volumn 109, Issue 3, 2010, Pages 509-518

  Pan, Weihua ^a   Xin, Ping ^a   Clawson, Gary A ^a,b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Library selection; microRNAs

Indexed keywords

CYTOKERATIN 19; MESSENGER RNA; MICRORNA; RIBONUCLEASE H;

ARTICLE; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; UNTRANSLATED REGION;

BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; HUMANS; KERATIN-19; MICRORNAS; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ALIGNMENT; TRANSFECTION;

EID: 74949135078     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22428     Document Type: Article

References (26)

1. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F, Wallace TM, Liu CG, Volinia S, Calin GA, Yfantis HG, Stephens RM, Croce CM. 2008. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 68:6162-6170.
2. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297.
3. Branch AD. 1998. Antisense drug discovery: Can cell-free screens speed the process? Antisense Nucleic Acid Drug Dev 8:249-254.
4. Bushati N, Cohen SM. 2007. microRNA functions. Annu Rev Cell Dev Biol 23:175-205.
5. Calin GA, Ferracin M, Cimmino A, di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. 2005. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353:1793-1801.
6. Clawson GA, Bui V, Xin P, Wang N, Pan W. 2008. Intracellular localization of the tumor suppressor HtrA1/Prss11 and its association with HPV16 E6 and E7 proteins. J Cell Biochem 105:81-88.
7. Duan S, Mathews DH, Turner DH. 2006. Interpreting oligonucleotide microarray data to determine RNA secondary structure: Application to the 3′ end of Bombyx mori R2 RNA. Biochemistry 45:9819-9832.
8. Esquela-Kerscher A, Slack FJ. 2006. Oncomirs-MicroRNAs with a role in cancer. Nat Rev Cancer 6:259-269.
9. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. 2007. miRBase: Tools for microRNA genomics. Nucleic Acids Res 36:D154-D158.
10. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magi E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. 2005. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065-7070.
11. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. 2008. Human microRNA targets. PLoS Biol 6:e264.
12. Kierzek E, Kierzek R, Turner DH, Catrina IE. 2006. Facilitating RNA structure prediction with microarrays. Biochemistry 45:581-593.
13. Kluiver J, Kroesen BJ, Poppema S, Van den Berg A. 2006. The role of microRNAs in normal hematopoiesis and hematopoietic malignancies. Leukemia 20:1931-1936.
14. Lu J, Getz G, Miska EA. 2005. MicroRNA expression profiles classify human cancers. Nature 435:834-838.
15. Milner N, Mir KU, Southern EM. 1997. Selecting effective antisense reagents on combinatorial oligonucleotide arrays. Nat Biotechnol 15:537-541.
16. Nilsen TW. 2007. Mechanisms of microRNA-mediated gene regulation in animal cells. Trends Genet 23:243-249.
17. Pan WH, Clawson GA. 2004. Identification of efficient cleavage sites in longtarget RNAs. Methods Mol Biol 252:125-144.
18. Pan WH, Clawson GA. 2006. Identifying accessible sites in RNA: The first step in designing antisense reagents. Curr Med Chem 13:3083-3103.
19. Pan W-H, Devlin H, Kelley C, Isom H, Clawson G. 2001. A selection system for identifying accessible sites in target RNAs. RNA 7:610-621.
20. Pan WH, Xin P, Bui V, Clawson G. 2003. Rapid identification of efficient target cleavage sites using a Hammerhead Ribozyme Library in an iterative manner. Mol Therapy 7:128-138.
21. Pan W, Xin P, Morrey J, Clawson G. 2004. A self-processing ribozyme cassette: Utility against human papillomavirus 11 E6/E7 mRNA and hepatitis B virus. Mol Therapy 9:596-606.
22. Rusinov V, Baev V, Minkov IN, Tabler M. 2005. MicroInspector: A web tool for detection of miRNA binding sites in an RNA sequence. Nucleic Acids Res 33:W696-W700.
23. Southern EM, Milner N, Mir KU. 1997. Discovering antisense reagents by hybridization of RNA to oligonucleotide arrays. Ciba Found Symp 209:38-46.
24. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrinki M, Harris CC, Croce CM. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257-2261.
25. Wu L, Belasco JG. 2008. Let me count the ways: Mechanisms of gene regulation by miRNAs and siRNAs. Mol Cell 29:1-7.
26. Zhang B, Pan X, Cobb GP, Anderson TA. 2007. microRNAs as oncogenes and tumor suppressors. Dev Biol 302:1-12.